BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23794078)

  • 21. Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.
    Andreas M; Zeitlinger M; Wisser W; Jaeger W; Maier-Salamon A; Thalhammer F; Kocher A; Hiesmayr JM; Laufer G; Hutschala D
    Eur J Cardiothorac Surg; 2015 Nov; 48(5):758-64. PubMed ID: 25527166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentrations of cefuroxime after continuous infusion in coronary bypass graft patients.
    Pass SE; Miyagawa CI; Healy DP; Ivey TD
    Ann Pharmacother; 2001 Apr; 35(4):409-13. PubMed ID: 11302401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens.
    Asín-Prieto E; Soraluce A; Trocóniz IF; Campo Cimarras E; Sáenz de Ugarte Sobrón J; Rodríguez-Gascón A; Isla A
    Int J Antimicrob Agents; 2015 May; 45(5):504-11. PubMed ID: 25758019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery.
    Barbour A; Schmidt S; Rout WR; Ben-David K; Burkhardt O; Derendorf H
    Int J Antimicrob Agents; 2009 Sep; 34(3):231-5. PubMed ID: 19411164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefuroxime as antibiotic prophylaxis in coronary artery bypass grafting surgery.
    Mastoraki S; Michalopoulos A; Kriaras I; Geroulanos S
    Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):442-6. PubMed ID: 17669893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study to determine the feasibility of continuous cefazolin infusion.
    Waltrip T; Lewis R; Young V; Farmer M; Clayton S; Myers S; Gray LA; Galandiuk S
    Surg Infect (Larchmt); 2002; 3(1):5-9. PubMed ID: 12593694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic Model for Cefuroxime Dosing during Cardiac Surgery under Cardiopulmonary Bypass.
    Lanoiselée J; Zufferey PJ; Hodin S; Tamisier N; Gergelé L; Palao JC; Campisi S; Molliex S; Morel J; Delavenne X; Ollier E
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 33020154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ceftriaxone vs cefuroxime for infection prophylaxis in coronary bypass surgery.
    Sisto T; Laurikka J; Tarkka MR
    Scand J Thorac Cardiovasc Surg; 1994; 28(3-4):143-8. PubMed ID: 7792559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of vancomycin and cefuroxime for infection prophylaxis in coronary artery bypass surgery.
    Vuorisalo S; Pokela R; Syrjälä H
    Infect Control Hosp Epidemiol; 1998 Apr; 19(4):234-9. PubMed ID: 9605271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic antibiotics for spine surgery: description of a regimen and its rationale.
    Riley LH
    J South Orthop Assoc; 1998; 7(3):212-7. PubMed ID: 9781898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime.
    Mastoraki E; Michalopoulos A; Kriaras I; Mouchtouri E; Falagas ME; Karatza D; Geroulanos S
    J Infect; 2008 Jan; 56(1):35-9. PubMed ID: 17983660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone, subcutaneous tissue and plasma pharmacokinetics of cefuroxime in total knee replacement patients - a randomized controlled trial comparing continuous and short-term infusion.
    Tøttrup M; Søballe K; Bibby BM; Hardlei TF; Hansen P; Fuursted K; Birke-Sørensen H; Bue M
    APMIS; 2019 Dec; 127(12):779-788. PubMed ID: 31515843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Intraoperative Continuous-Infusion Versus Intermittent Dosing of Cefazolin Therapy on the Incidence of Surgical Site Infections After Coronary Artery Bypass Grafting.
    Shoulders BR; Crow JR; Davis SL; Whitman GJ; Gavin M; Lester L; Barodka V; Dzintars K
    Pharmacotherapy; 2016 Feb; 36(2):166-73. PubMed ID: 26799442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative antibiotic prophylaxis with cefuroxime in oral-maxillofacial surgical procedures.
    Alfter G; Schwenzer N; Friess D; Möhrle E
    J Craniomaxillofac Surg; 1995 Feb; 23(1):38-41. PubMed ID: 7699082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of the serum antibiotic levels during open heart surgery (ceftazidim, ciprofloxacin, clindamycin).
    Lonský V; Dominik J; Mand'ák J; Pozlerová E; Hejzlar M; Lonská V; Marsíková M; Kubícek J; Snítilová M
    Acta Medica (Hradec Kralove); 2000; 43(1):23-7. PubMed ID: 10934782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tranexamic acid and convulsive seizures after isolated coronary artery bypass surgery: the role of cardiopulmonary bypass and renal function.
    Hulde N; Zittermann A; Deutsch MA; von Dossow V; Gummert JF; Koster A
    Interact Cardiovasc Thorac Surg; 2020 Apr; 30(4):538-540. PubMed ID: 31958119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefuroxime concentrations in the anterior and posterior column of the lumbar spine - an experimental porcine study.
    Hvistendahl MA; Bue M; Hanberg P; Kaspersen AE; Schmedes AV; Stilling M; Høy K
    Spine J; 2022 Sep; 22(9):1434-1441. PubMed ID: 35671945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High pressure liquid chromatographic analysis of the serum concentration of cefuroxime after an intravenous bolus injection of cefuroxime in patients with a coronary artery bypass grafting.
    Koot MJ; IJdenberg FN; Stuurman RM; Poell J; Bras LJ; Langemeijer JJ; Lie-A-Huen L
    Pharm Weekbl Sci; 1992 Dec; 14(6):360-4. PubMed ID: 1475176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass.
    Calic D; Ariano RE; Arora RC; Grocott HP; Lakowski TM; Lillico R; Zelenitsky SA
    J Antimicrob Chemother; 2018 Mar; 73(3):768-771. PubMed ID: 29237016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of Prophylactic Ampicillin-Sulbactam and Dosing Optimization in Patients Undergoing Cardiovascular Surgery with Cardiopulmonary Bypass.
    Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Yamamoto H; Imoto Y; Morikawa N; Takeda Y
    Biol Pharm Bull; 2015; 38(11):1817-21. PubMed ID: 26521833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.